Thumbnail Image
Publication

Breast Cancer Drugs are More Expensive in the 7th Congressional District in Maryland than in Foreign Countries

House Committee on Government Reform
; 
Special Investigations Division
Abstract
The Special Investigations Division of the House Committee on Government Reform investigated the pricing of five commonly prescribed brand-name prescription drugs for breast cancer in Representitive Cumming’s district in Maryland. The report states uninsured women in this district face substantially higher costs, with the average price for these drugs being 155% higher than in Canada, the U.K., France, and Italy. Breast cancer drugs are over three times more expensive in this district than in Canada and France. These findings underscore the disparity in breast cancer drug prices between Rep. Cummings's district and other countries, with substantial implications for the financial burden on patients.
Date
2000-10-01
Document Type
House Minority Staff Report
Serial Number
Document Length
14 pages
Congress
106
Show all metadata
Files
Thumbnail Image
2000-10-01_R-Breast_Cancer_Drugs_MD-106C.pdf
Adobe PDF, 53.43 KB
URI
https://hdl.handle.net/20.500.14300/1455
Relation
DOI
Keywords
Staff Reports
PAP Major Code
3: Health
PAP Minor Code
335: Prescription Drug Coverage and Costs
Related Hearings
Press Releases and Contextual Information
Collections
House Oversight Committee